Level Biotechnology (Taiwan) Today
| 3118 Stock | TWD 32.35 0.05 0.15% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Level Biotechnology is selling for under 32.35 as of the 12th of December 2024; that is 0.15% up since the beginning of the trading day. The stock's lowest day price was 32.25. Level Biotechnology has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 18th of December 2023 and ending today, the 12th of December 2024. Click here to learn more.
Level Biotechnology Inc. markets and distributes cell culture, immunology, molecular biology products and biomedical precision equipment in Taiwan. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan. LEVEL BIOTECHNOLOGY operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. The company has 32.45 M outstanding shares. More on Level Biotechnology
Moving together with Level Stock
| 0.61 | 4743 | Oneness Biotech | PairCorr |
| 0.7 | 6547 | Medigen Vaccine Biologics | PairCorr |
| 0.79 | 4174 | OBI Pharma | PairCorr |
Moving against Level Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Level Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Level Biotechnology's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Level Biotechnology or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Biotech (View all Themes) |
| Business Concentration | Biotech, Biotechnology, Healthcare (View all Sectors) |
Level Biotechnology (3118) is traded on Taiwan OTC Exchange in Taiwan and employs 121 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 928.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Level Biotechnology's market, we take the total number of its shares issued and multiply it by Level Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Level Biotechnology operates under Healthcare sector and is part of Biotechnology industry. The entity has 32.45 M outstanding shares.
Level Biotechnology has accumulated about 295.07 M in cash with 155.95 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.09.
Check Level Biotechnology Probability Of Bankruptcy
Ownership AllocationLevel Biotechnology maintains a total of 32.45 Million outstanding shares. Level Biotechnology holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Level Ownership Details
Level Biotechnology Risk Profiles
Although Level Biotechnology's alpha and beta are two of the key measurements used to evaluate Level Biotechnology's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.4281 | |||
| Standard Deviation | 0.5627 | |||
| Variance | 0.3166 | |||
| Risk Adjusted Performance | (0.01) |
Level Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Level Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Additional Tools for Level Stock Analysis
When running Level Biotechnology's price analysis, check to measure Level Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Level Biotechnology is operating at the current time. Most of Level Biotechnology's value examination focuses on studying past and present price action to predict the probability of Level Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Level Biotechnology's price. Additionally, you may evaluate how the addition of Level Biotechnology to your portfolios can decrease your overall portfolio volatility.